Subscribe to Newsletter

Trends & Forecasts

Business & Regulation Trends & Forecasts

Tap the App

| Francesco Patalano | 4 min read

What can science learn from patients, and how can patients benefit from being in control of their own health?

Business & Regulation Trends & Forecasts

Patient-Centric Perspectives

| Keri Yale | 5 min read

Patient-centricity needs to be more than a buzzword. Here’s how Boehringer Ingelheim is weaving it into its culture.

Business & Regulation Digital Technologies

Video: Matthew Lakelin on Improving Supply Chain Efficiency

| Rob Coker

A video interview covering supply chain improvement technology

Manufacture Bioprocessing - Upstream & Downstream

Video: Natalia Elizalde Discusses the Challenges of Viral Vectors

| Stephanie Vine

A video interview discussing the challenges of viral vectors

Manufacture Advanced Medicine

Video: Ivan Wall Speaks Out About Cell and Gene Training

| Stephanie Vine

A video interview addressing the need for training in cell and gene therapy manufacturing.

Manufacture Advanced Medicine

Video: Vered Caplan Talks Advanced Therapies

| Stephanie Vine

Check out our video interview covering decentralized manufacturing and more.

Manufacture Bioprocessing - Upstream & Downstream

Welcome to the CRISPR Powerhouse

| Eric Rhodes | 4 min read

Why 2023 is the year that antibody manufacturers should embrace CRISPR gene editing.

Business & Regulation Trends & Forecasts

Weathering the Storm: Cell and Gene’s Economic Downturn

| James Wilson, Anshul Mangal | 5 min read

An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?

Business & Regulation Business Practice

Biotechs in the Baltic

| Angus Stewart | 12 min read

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

Business & Regulation Trends & Forecasts

Winter is Coming: How the Energy Crisis Will Change Pharma in 2023

| Angus Stewart | 6 min read

In the face of war and the economic fallout of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register